Plantaricin A
| Internal ID | 4633d38d-482b-4650-be5e-57518633af06 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Oligopeptides |
| IUPAC Name | 2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-N-[1-[[2-[[1-[[3-hydroxy-1-[[1-[(3-methyl-1-oxopentan-2-yl)amino]-1-oxopropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]pentanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C46H75N11O14S/c1-9-24(4)34(21-58)55-39(64)26(6)51-46(71)38(27(7)60)57-40(65)25(5)50-37(63)20-49-42(67)32(16-17-72-8)53-43(68)31(14-15-36(48)62)52-44(69)33(18-23(2)3)54-45(70)35(22-59)56-41(66)30(47)19-28-10-12-29(61)13-11-28/h10-13,21,23-27,30-35,38,59-61H,9,14-20,22,47H2,1-8H3,(H2,48,62)(H,49,67)(H,50,63)(H,51,71)(H,52,69)(H,53,68)(H,54,70)(H,55,64)(H,56,66)(H,57,65) |
| InChI Key | XWJYGTDYKZLURA-UHFFFAOYSA-N |
| Popularity | 25 references in papers |
| Molecular Formula | C46H75N11O14S |
| Molecular Weight | 1038.20 g/mol |
| Exact Mass | 1037.52156728 g/mol |
| Topological Polar Surface Area (TPSA) | 434.00 Ų |
| XlogP | -1.80 |
| Atomic LogP (AlogP) | -4.02 |
| H-Bond Acceptor | 16 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 33 |
| DTXSID801055294 |
| 2-((2-((2-((2-amino-3-(4-hydroxyphenyl)propanoyl)amino)-3-hydroxypropanoyl)amino)-4-methylpentanoyl)amino)-N-(1-((2-((1-((3-hydroxy-1-((1-((3-methyl-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxobutan-2-yl)amino)-1-oxopropan-2-yl)amino)-2-oxoethyl)amino)-4-methylsulfanyl-1-oxobutan-2-yl)pentanediamide |
| 131463-18-8 |
| Plantaricin A |
| CHEBI:225696 |
| 2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-N-[1-[[2-[[1-[[3-hydroxy-1-[[1-[(3-methyl-1-oxopentan-2-yl)amino]-1-oxopropan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulanyl-1-oxobutan-2-yl]pentanediamide |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9434 | 94.34% |
| Caco-2 | - | 0.8657 | 86.57% |
| Blood Brain Barrier | - | 0.6500 | 65.00% |
| Human oral bioavailability | - | 0.7143 | 71.43% |
| Subcellular localzation | Mitochondria | 0.6268 | 62.68% |
| OATP2B1 inhibitior | - | 0.8590 | 85.90% |
| OATP1B1 inhibitior | + | 0.8303 | 83.03% |
| OATP1B3 inhibitior | + | 0.9247 | 92.47% |
| MATE1 inhibitior | - | 0.9200 | 92.00% |
| OCT2 inhibitior | - | 0.7250 | 72.50% |
| BSEP inhibitior | + | 0.8665 | 86.65% |
| P-glycoprotein inhibitior | + | 0.7410 | 74.10% |
| P-glycoprotein substrate | + | 0.8932 | 89.32% |
| CYP3A4 substrate | + | 0.7090 | 70.90% |
| CYP2C9 substrate | - | 0.8022 | 80.22% |
| CYP2D6 substrate | - | 0.7963 | 79.63% |
| CYP3A4 inhibition | - | 0.7665 | 76.65% |
| CYP2C9 inhibition | - | 0.8637 | 86.37% |
| CYP2C19 inhibition | - | 0.8374 | 83.74% |
| CYP2D6 inhibition | - | 0.8095 | 80.95% |
| CYP1A2 inhibition | - | 0.8680 | 86.80% |
| CYP2C8 inhibition | + | 0.7064 | 70.64% |
| CYP inhibitory promiscuity | - | 0.9820 | 98.20% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8400 | 84.00% |
| Carcinogenicity (trinary) | Non-required | 0.6746 | 67.46% |
| Eye corrosion | - | 0.9862 | 98.62% |
| Eye irritation | - | 0.8984 | 89.84% |
| Skin irritation | - | 0.8038 | 80.38% |
| Skin corrosion | - | 0.9311 | 93.11% |
| Ames mutagenesis | - | 0.8000 | 80.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6528 | 65.28% |
| Micronuclear | + | 0.6900 | 69.00% |
| Hepatotoxicity | - | 0.6541 | 65.41% |
| skin sensitisation | - | 0.8693 | 86.93% |
| Respiratory toxicity | + | 0.7556 | 75.56% |
| Reproductive toxicity | + | 0.8667 | 86.67% |
| Mitochondrial toxicity | + | 0.7000 | 70.00% |
| Nephrotoxicity | - | 0.5839 | 58.39% |
| Acute Oral Toxicity (c) | III | 0.7592 | 75.92% |
| Estrogen receptor binding | + | 0.7924 | 79.24% |
| Androgen receptor binding | + | 0.6964 | 69.64% |
| Thyroid receptor binding | + | 0.5699 | 56.99% |
| Glucocorticoid receptor binding | + | 0.6238 | 62.38% |
| Aromatase binding | + | 0.6580 | 65.80% |
| PPAR gamma | + | 0.7747 | 77.47% |
| Honey bee toxicity | - | 0.7226 | 72.26% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.7100 | 71.00% |
| Fish aquatic toxicity | - | 0.5551 | 55.51% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.91% | 98.95% |
| CHEMBL236 | P41143 | Delta opioid receptor | 99.80% | 99.35% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.03% | 89.63% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 98.66% | 97.23% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 97.83% | 100.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.54% | 93.56% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 96.82% | 83.82% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 96.63% | 90.20% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 96.59% | 91.11% |
| CHEMBL3286 | P00749 | Urokinase-type plasminogen activator | 96.27% | 97.88% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.04% | 96.09% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 95.49% | 93.10% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.30% | 100.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.88% | 99.17% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 94.52% | 90.17% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 93.80% | 98.05% |
| CHEMBL301 | P24941 | Cyclin-dependent kinase 2 | 92.50% | 91.23% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 92.26% | 99.17% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 92.07% | 98.94% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 91.05% | 98.89% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 90.15% | 97.21% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 90.14% | 95.50% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 90.00% | 95.38% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 89.97% | 96.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 89.03% | 90.71% |
| CHEMBL2535 | P11166 | Glucose transporter | 88.79% | 98.75% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 88.36% | 89.50% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 87.73% | 96.67% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 87.12% | 92.29% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 86.87% | 94.45% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.11% | 96.90% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 85.02% | 94.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 84.31% | 97.14% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 84.13% | 92.80% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 84.02% | 85.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 83.82% | 93.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.78% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 83.27% | 91.19% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 83.25% | 95.56% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 83.16% | 97.29% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 82.96% | 97.09% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 82.48% | 95.00% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 82.21% | 96.37% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 81.95% | 96.28% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 81.48% | 95.89% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 81.04% | 97.43% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 80.69% | 91.71% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 80.69% | 89.33% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 80.16% | 83.10% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139587859 |
| LOTUS | LTS0049914 |
| wikiData | Q104397986 |